The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 343:146-147 July 13, 2000 Number 2
NextNext

Disclosure of Authors' Conflicts of Interest — A Follow-Up

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Angell, M.
-Related Article
To the Editor: In the February 24th issue, 19 cases were identified in which authors of Drug Therapy articles were in violation of the Journal 's conflict-of-interest policy for review articles and editorials.1 According to this policy, "authors of such articles will not have any financial interest in a company (or its competitor) that makes a product discussed in the article."2 Although no wrongdoing was implied, one cannot look at this matter without thinking that, in some small way, the authors have been discredited.

There are several problems with the Journal 's analysis of these cases. First, only the Drug . . . [Full Text of this Article]

References


Related Letters:

Disclosure of Authors' Conflicts of Interest: A Follow-Up
Angell M., Utiger R. D., Wood A. J.J.
Extract | Full Text  
N Engl J Med 2000; 342:586-587, Feb 24, 2000. Correspondence


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.